Ftse Mib
34.228,77
0,71%
DAX
18.430,05
1,42%
S&P 500
5.187,70
0,13%
NASDAQ
16.339,84
-0,06%
Bitcoin
63.148,93
-0,03%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Century Therapeutics Inc (IPSC) Century Therapeutics Inc (IPSC) Notizie

IPSC

Century Therapeutics (IPSC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IPSC
DataOraFonteTitoloSimboloCompagnia
06/05/202422:52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
23/04/202413:00GlobeNewswire Inc.Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitNASDAQ:IPSCCentury Therapeutics Inc
11/04/202413:00GlobeNewswire Inc.Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade TherapeuticsNASDAQ:IPSCCentury Therapeutics Inc
08/04/202422:05GlobeNewswire Inc.Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:IPSCCentury Therapeutics Inc
25/03/202412:00GlobeNewswire Inc.Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of DirectorsNASDAQ:IPSCCentury Therapeutics Inc
19/03/202412:00GlobeNewswire Inc.Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceNASDAQ:IPSCCentury Therapeutics Inc
14/03/202412:30GlobeNewswire Inc.Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdatesNASDAQ:IPSCCentury Therapeutics Inc
09/03/202400:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
06/03/202400:03GlobeNewswire Inc.Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:IPSCCentury Therapeutics Inc
21/02/202419:04Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:IPSCCentury Therapeutics Inc
01/02/202413:00GlobeNewswire Inc.Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:IPSCCentury Therapeutics Inc
19/01/202423:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPSCCentury Therapeutics Inc
09/12/202318:00GlobeNewswire Inc.Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ EditsNASDAQ:IPSCCentury Therapeutics Inc
06/12/202322:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
06/12/202313:30GlobeNewswire Inc.Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus ErythematosusNASDAQ:IPSCCentury Therapeutics Inc
06/12/202313:30GlobeNewswire Inc.Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus ErythematosusNASDAQ:IPSCCentury Therapeutics Inc
21/11/202313:00GlobeNewswire Inc.Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:IPSCCentury Therapeutics Inc
09/11/202313:01GlobeNewswire Inc.Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:IPSCCentury Therapeutics Inc
09/11/202313:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IPSCCentury Therapeutics Inc
09/11/202313:00GlobeNewswire Inc.Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory DiseasesNASDAQ:IPSCCentury Therapeutics Inc
09/11/202313:00GlobeNewswire Inc.Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive OfficerNASDAQ:IPSCCentury Therapeutics Inc
02/11/202314:00GlobeNewswire Inc.Century Therapeutics to Present Initial Clinical Data Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits at the 65th ASH Annual Meeting and ExpositionNASDAQ:IPSCCentury Therapeutics Inc
26/09/202313:00GlobeNewswire Inc.Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines ConferenceNASDAQ:IPSCCentury Therapeutics Inc
09/08/202313:30GlobeNewswire Inc.Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:IPSCCentury Therapeutics Inc
29/06/202322:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IPSCCentury Therapeutics Inc
11/05/202313:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IPSCCentury Therapeutics Inc
11/05/202313:30GlobeNewswire Inc.Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:IPSCCentury Therapeutics Inc
05/05/202322:46Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:IPSCCentury Therapeutics Inc
05/05/202322:41Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IPSCCentury Therapeutics Inc
28/04/202322:11Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:IPSCCentury Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IPSC

La tua Cronologia

BIT
RACE
Ferrari NV
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ISP
Intesa Sanpaolo
BIT
CPR
Davide Campari
BIT
STMMI
ST Microelectronics
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
LDO
Leonardo
BIT
FBK
Finecobank
BIT
ENI
Eni
BIT
IRE
Iren
BIT
G
Generali
BIT
SRG
Snam
BIT
BAMI
Banco BPM
BIT
BPE
Bper Banca
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network